Literature DB >> 7585065

Genetic instability occurs in the majority of young patients with colorectal cancer.

B Liu1, S M Farrington, G M Petersen, S R Hamilton, R Parsons, N Papadopoulos, T Fujiwara, J Jen, K W Kinzler, A H Wyllie, B Vogelstein, M G Dunlop.   

Abstract

Replication errors (RER) associated with genetic instability have been found in cancers of several different types and particularly in the tumours of patients with hereditary non-polyposis colorectal cancer (HNPCC). We have here determined the prevalence of such instability in relation to age among patients without HNPCC. Colorectal cancers (CRCs) in the majority of patients 35 years of age or younger exhibited instability (58% of 31 patients), whereas CRCs from patients older than 35 uncommonly did (12% of 158, p < 0.0001). Twelve of the patients under 35 with instability were evaluated for alterations of mismatch repair genes, and five were found to harbour germline mutations. These data suggest that the mechanisms underlying tumour development in young CRC patients differ from those in most older patients, regardless of HNPCC status. The results have important implications for genetic testing and management of young CRC patients and their families.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7585065     DOI: 10.1038/nm0495-348

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  79 in total

1.  Relationship between grade of microsatellite instability and target genes of mismatch repair pathways in sporadic colorectal carcinoma.

Authors:  G Togo; Y Shiratori; M Okamoto; Y Yamaji; M Matsumura; T Sano; T Motojima; M Omata
Journal:  Dig Dis Sci       Date:  2001-08       Impact factor: 3.199

2.  Hypermutability at a poly(A/T) tract in the human germline.

Authors:  A L Bacon; M G Dunlop; S M Farrington
Journal:  Nucleic Acids Res       Date:  2001-11-01       Impact factor: 16.971

3.  Microsatellite instability and the clinicopathological features of sporadic colorectal cancer.

Authors:  R Ward; A Meagher; I Tomlinson; T O'Connor; M Norrie; R Wu; N Hawkins
Journal:  Gut       Date:  2001-06       Impact factor: 23.059

4.  MSH6 and MUTYH deficiency is a frequent event in early-onset colorectal cancer.

Authors:  María Dolores Giráldez; Francesc Balaguer; Luis Bujanda; Miriam Cuatrecasas; Jenifer Muñoz; Virginia Alonso-Espinaco; Mikel Larzabal; Anna Petit; Victoria Gonzalo; Teresa Ocaña; Leticia Moreira; José María Enríquez-Navascués; C Richard Boland; Ajay Goel; Antoni Castells; Sergi Castellví-Bel
Journal:  Clin Cancer Res       Date:  2010-10-05       Impact factor: 12.531

5.  Mucinous adenocarcinoma showing different clinicopathological and molecular characteristics in relation to different colorectal cancer subgroups.

Authors:  J M Chiang; C Y Yeh; C R Changchien; J S Chen; R Tang; J R Chen
Journal:  Int J Colorectal Dis       Date:  2010-06-08       Impact factor: 2.571

6.  The "comparative growth assay": examining the interplay of anti-cancer agents with cells carrying single gene alterations.

Authors:  P Hausner; D J Venzon; L Grogan; I R Kirsch
Journal:  Neoplasia       Date:  1999-10       Impact factor: 5.715

7.  Single nucleotide polymorphism seeking long term association with complex disease.

Authors:  Brian W Kirk; Matthew Feinsod; Reyna Favis; Richard M Kliman; Francis Barany
Journal:  Nucleic Acids Res       Date:  2002-08-01       Impact factor: 16.971

8.  Growth stimulation of tumor-specific cytotoxic T lymphocytes on concanavalin a-immobilized carrier beads.

Authors:  S Q Liu; L S Liu; T Ohno
Journal:  Cytotechnology       Date:  1998-01       Impact factor: 2.058

9.  Alternative genetic pathways in colorectal carcinogenesis.

Authors:  S Olschwang; R Hamelin; P Laurent-Puig; B Thuille; Y De Rycke; Y J Li; F Muzeau; J Girodet; R J Salmon; G Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-28       Impact factor: 11.205

Review 10.  Colorectal cancer in young adults.

Authors:  Jennifer A Inra; Sapna Syngal
Journal:  Dig Dis Sci       Date:  2014-12-06       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.